Comprehensive UPLC-MS/MS Method for Quantifying Four Key Intestinal Permeability Markers in Caco-2 Models
Molecules · 2025
DOI: 10.3390/molecules30173477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Luciana Silva de Araújo und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. Prof. Dr. Zeferino Vaz, s/n, Ribeirão Preto 14040-903, SP, Brazil. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Intestinal Mucosa, Intestinal Absorption. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeicoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
A comprehensive UPLC-MS/MS method was developed and validated for the simultaneous separation and quantification of atenolol, propranolol, quinidine, and verapamil, using established intestinal permeability standards in the Caco-2 cell monolayer model. This in vitro model is widely accepted for predicting intestinal drug permeability and is formally recognized by global regulatory agencies, including the FDA, EMA, and WHO, as a surrogate for assessing drug permeability in biowaiver applications under the Biopharmaceutics Classification System (BCS) framework. Despite its regulatory importance, standardized methods for the simultaneous quantification of key permeability markers remain scarce. The selected compounds represent distinct transport pathways: paracellular (atenolol), passive transcellular (propranolol, verapamil), and P-glycoprotein-mediated efflux (quinidine). Method validation followed FDA guidelines and demonstrated high selectivity, linearity (r2 > 0.998), precision, and accuracy. Solid-phase extraction enhanced recovery and reduced matrix effects. Application to Caco-2 permeability assays confirmed expected transport profiles, including P-gp inhibition effects with verapamil. By integrating multiple analytes in a single workflow, the method improves analytical throughput, supports mechanistic interpretation, and ensures consistency across assays. This advanced separation strategy, combined with sensitive mass spectrometric detection, supports regulatory and BCS-based classification studies, contributing to the standardization of permeability assessments in drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. Prof. Dr. Zeferino Vaz, s/n, Ribeirão Preto 14040-903, SP, Brazil.
- Chemistry Department, School of Philosophy, Sciences and Languages, University of São Paulo, Av. Bandeirantes, 3900, Ribeirão Preto 14040-901, SP, Brazil.
ORCID-Profile: Luciana Silva de Araújo, Eduardo José Crevelin, Niege Araçari Jacometti Cardoso Furtado
Förderung
- National Council for Scientific and Technological Development
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- São Paulo Research Foundation, FAPESP
- Coordination for the Improvement of Higher Education Personnel
Zitieren
APA
Araújo, L. S., Crevelin, E. J., Moraes, L. A. B., & Jacometti Cardoso Furtado, N. A. (2025). Comprehensive UPLC-MS/MS Method for Quantifying Four Key Intestinal Permeability Markers in Caco-2 Models. Molecules. https://doi.org/10.3390/molecules30173477
Vancouver
Araújo LS, Crevelin EJ, Moraes LAB, Jacometti Cardoso Furtado NA. Comprehensive UPLC-MS/MS Method for Quantifying Four Key Intestinal Permeability Markers in Caco-2 Models. Molecules. 2025. doi:10.3390/molecules30173477
BibTeX
@article{Arajo2025,
author = {Araújo, Luciana Silva de and Crevelin, Eduardo José and Moraes, Luiz Alberto Beraldo de and Jacometti Cardoso Furtado, Niege Araçari},
title = {Comprehensive UPLC-MS/MS Method for Quantifying Four Key Intestinal Permeability Markers in Caco-2 Models},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30173477}
}
EUVIMED